Regel Therapeutics

About:

Regel Therapeutics provides gene therapy that significantly improve the lives of people with life-threatening genetic illnesses.

Website: https://regeltherapeutics.com/

Top Investors: HS Chau Foundation

Description:

Regel Therapeutics is dedicated to revolutionizing gene therapy and transforming patient outcomes across a variety of indications by utilizing its unique platform technology.

Total Funding Amount:

$1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2020-01-01

Contact Email:

info(AT)regeltherapeutics.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2023-09-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai